- Maubeuge, France
- https://jobs.cntertech.com/employer/sermorelin-vs-cjc-1295-a-side-by-side-comparison-of-growth-hormone-releasing-peptides/
-
The only long-term trial was discontinued because of a case of deadly myocardial infarction, deemed unrelated to CJC-1295 itself 9.
- Joined on
2025-10-17
Block a user
There are no packages yet.
For more information on the package registry, see the documentation.